`
`Illumina Ex. 1134
`IPR Petition - USP 10,435,742
`
`
`
`Application No.
`FirsIAcIion Interview Pilot Program 16/159185
`Pre-lnleri/iew Communication
`Exam '“e'
`JEZIA RILEY
`
`Applicant(s)
`JA” et al_'
`" ”n“
`1637
`
`NA 3
`N0
`
`tatus
`
`- The MAILING 0/? N077F/CA 770/V DA TE of this communication appears on the cover sheet wit/7 the correspondence address -
`
`THE SHORTENED STATUTORY PERIOD FOR REPLY IS SET TO EXPIRE ONE MONTH OR THIRTY (30) DAYS,
`WHICHEVER IS LONGER, FROM THE MAILING OR NOTIFICATION DATE OF THIS COMMUNICATION.
`
`This time period for reply is extendable under 37 CFR 1.136(a) for only ONE additional MONTH.
`
`This communication constitutes notice under 37 CFR 1.136(a)(1)(i).
`Applicant must, within the time period for reply, file: (1) A letter requesting not to have a first action interview; (2) A reply under 37 CFR
`1.111 waiving the first action interview and First Action Interview Office Action; or (3) An Applicant Initiated Interview Request Form (PTOL-
`413A) electronically via EFS-Web, accompanied by a proposed amendment or arguments, and schedule the interview within 2 months from
`the filing of the request. A failure to respond to this communication will be treated as a request not to have an interview. If applicant waives
`the First Action Interview Office Action, the instant Pre-lnterview Communication is deemed the first Office Action on the Merits. The next
`subsequent Office action may be made final if appropriate. See MPEP 706.07( ).
`
`Status
`
`1) [:1 Responsive to communication(s) filed on
`
`C] A declaration(s)/affidavit(s) under 37 CFR 1.130(b) was/were filed on
`
`.
`
`Disposition of Claims
`
`2) 33 Claim(s) fl is/are pending in the application.
`
`2a) Of the above claim(s)
`
`is/are withdrawn from consideration.
`
`:I Claim(s)
`
`is/are allowed.
`
`ZI Claim s fl is/are rejected.
`(
`)
`
`j Claim(s)
`
`is/are objected to.
`
`:I Claim s
`(
`
`)
`
`are subject to restriction and/or election requirement.
`
`) ) ) )
`
`
`
`
`
`Application Papers
`
`7) :I The specification is objected to by the Examiner.
`8) 2} The drawing(s) filed on 10/2/18 is/are: a)
`accepted or b) CI objected to by the Examiner.
`
`Applicant may not request that any objection to the drawing(s) be held in abeyance. See 37 CFR 1.85(a).
`Replacement drawing sheet(s) including the correction is required if the drawing(s) is objected to. See 37 CFR 1.121 (d).
`
`Priority under 35 U.S.C. § 119
`
`9) CI Acknowledgment is made of a claim for foreign priority under 35 U.S.C. § 119( )-(d) or (f).
`
`a) C] All b) C] Some * c) C] None of:
`
`1. CI Certified copies of the priority documents have been received.
`
`2. I:I Certified copies of the priority documents have been received in Application No.
`
`3. CI Copies of the certified copies of the priority documents have been received in this National
`Stage application from the International Bureau (PCT Rule 17.2( )).
`
`*See the attached detailed Office action for a list of the certified copies not received.
`
`Contact Information
`
`Examiner's Telephone Number: (571)272—0786
`
`Examiner's Typical Work Schedule: 7:30—6:009m
`
`Supervisor's Name: Gary Benzion
`
`Attachment(s)
`
`1) D Notice of References Cited (PTO-892)
`
`Supervisor's Telephone Number:
`571—272—0782
`
`3) 1:] Interview Summary (PTO-413)
`Paper No(s)/Mail Date.
`
`2) D Information Disclosure Statement(s) (PTO/SB/OB)
`Paper No(s)/Mail Date
`.
`U.S.Patent and Trademark Office
`
`4) C] Other:
`
`PTOL-413FP (Rev. 08-13)
`
`First Action Interview Pilot Program - Pre-lnterview Communication
`
`Part Of Paper No./Mail Date 20190214
`
`Pa e1 of2
`g
`
`Page 1
`
`Page 1
`
`
`
`Firs! Action Interview Pilot Program
`Pro-Interview Communication
`
`Exam'mr
`JEZIA RILEY
`
`A" ”n“
`1637
`
`“A Status
`N0
`
`Application No.
`
`16/150,185
`
`Applicant(s)
`
`Ju etal.
`
`.
`fl Claim(s)
`
`Reference(s)
`(if applicable)
`
`1
`
`1—2
`
`US 9,719,139
`
`Notification of Rejection(s) and/or 0bjection(s)
`Rejection
`.
`.
`.
`.
`Statutory Basis
`Brief Explanation of Rejection
`Claims 1—2 are rejected on the ground of nonstatutory double patenting rejection as being
`unpatentable over claim 1 of US. Patent No. 9,719,139. Although the claims at issue are not
`identical, they are not patentably distinct from each other (see below)
`
`Double patenting
`
`
`
`Expanded Discussion/Commentary
`
`because they both claim a nucleotide having identical formula where R can be MOM (see Figure 7) and therefore is not a —CHZCH=CH2 group.
`And OR is not a methoxy group or an ester group.
`
`DATE:
`14 February 2019
`
`/JEZIA RILEY/
`Primary Examiner, Art Unit 1637
`
`U.S.Patent and Trademark Office
`
`PTOL-413FP (Rev. 08-13)
`
`First Action Interview Pilot Program - Pre-lnterview Communication Part of Paper NoJMaiI Date 20190214
`
`Pa e 2 of2
`g
`
`Page 2
`
`Page 2
`
`